Home > Insider Trading > Filing (0001127602-13-035791)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
850693	Allergan Inc	AGN	Pharmaceutical Preparations (2834)	951622442

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1532023	S Julian Gangolli	2525 Dupont Drive Irvine CA 92612	Cvp & Pres, North America	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-12-27	15,000	$40.16	23,047	No	4	M	Direct
Common Stock	Disposition	2013-12-27	15,000	$110.17	8,047	No	4	S	Direct
Common Stock	Acquisiton	2013-12-27	37,500	$59.13	45,547	No	4	M	Direct
Common Stock	Disposition	2013-12-27	37,500	$110.00	8,047	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2013-12-27	15,000	$0.00	15,000	$40.16
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2013-12-27	37,500	$0.00	37,500	$59.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2019-02-20	No	4	M	Direct
12,500		2020-02-22	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	220	Indirect	By ESOP Trust
Common Stock	16,900	Indirect	By The Gangolli Family Trust
Common Stock	264	Indirect	By Wife's 401(k) plan

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 9, 2013.
Includes shares acquired under the Allergan, Inc. Dividend Reinvestment Plan.
Shares allocated to the reporting person's ESOP account as of reporting date.
Shares held by The Gangolli Family Trust established June 1, 2011, of which the reporting person and his spouse are each trustees.
The option became exercisable in four equal annual installments beginning February 20, 2010. The remaining outstanding options for this award are reported in this filing.
The option became exercisable in four equal annual installments beginning February 22, 2011.